Effect of intravenous immunoglobulin with or without cytotoxic drugs on pemphigus intercellular antibodies

Journal of the American Academy of Dermatology

Volumn 64, Issue 3, 2011, Pages 484-489

  Lolis, Margarita ^a   Toosi, Siavash ^a   Czernik, Annette ^a   Bystryn, Jean Claude ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

azathioprine; cyclophosphamide; cytotoxic; immunofluorescence; immunoglobulin; intercellular antibodies; intravenous; pemphigus

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN; PEMPHIGUS ANTIBODY;

ADULT; AGED; ANEMIA; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; INJECTION SITE REACTION; MALE; MULTIPLE CYCLE TREATMENT; MYALGIA; PEMPHIGUS FOLIACEUS; PEMPHIGUS VULGARIS; PRIORITY JOURNAL; SIDE EFFECT;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; AUTOANTIBODIES; AZATHIOPRINE; CYCLOPHOSPHAMIDE; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MALE; MIDDLE AGED; PEMPHIGUS; RETROSPECTIVE STUDIES;

EID: 79951578832     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2010.04.001     Document Type: Article

References (13)

1. A. Ahmed Intravenous immunoglobulin therapy in the treatment of patients with pemphigus vulgaris unresponsive to conventional immunosuppressive treatment J Am Acad Dermatol 45 2001 679 690 (Pubitemid 33032563)
2. J.C. Bystryn, D. Jiao, and S. Natow Treatment of pemphigus with intravenous immunoglobulin J Am Acad Dermatol 47 2002 358 363
3. S. Segura, P. Iranzo, I. Martinez, JM JR Mascaro, M. Alsina, and J. Herrero High-dose intravenous immunoglobulins for the treatment of autoimmune blistering diseases: evaluation of its use in 19 cases J Am Acad Dermatol 56 2007 960 967 (Pubitemid 46720202)
4. J.C. Bystryn, and D. Jiao IVIg selectively and rapidly decreases circulating pathogenic autoantibodies in pemphigus vulgaris Autoimmunity 39 2006 601 607 (Pubitemid 44768929)
5. J.C. Bystryn Mechanism of action of IVIg in pemphigus J Invest Dermatol 118 2002 737
6. J.C. Bystryn, and J.L. Rudolph IVIg treatment of pemphigus: how it works and how to use it J Invest Dermatol 125 2005 1093 1098
7. J.C. Bystryn, I. Schenkein, and J.W. Uhr A model for the regulation of antibody synthesis by serum antibody: progress in immunology 1971 Academic Press New York
8. J.C. Bystryn Plasmapheresis therapy of pemphigus Arch Dermatol 124 1988 1702 1704
9. J.R. Stanley Pemphigus I.M. Freedberg, A.Z. Eisen, K. Wolff, K.F. Austen, L.A. Goldsmith, S.I. Katz, Dermatology in general medicine 1999 McGraw-Hill New York 654 666
10. J.C. Bystryn, A. Akman, and D. Jiao Limitations in enzyme-linked immunosorbent assay for antibodies against desmogleins 1 and 3 in patients with pemphigus Arch Dermatol 138 2002 1252 1253 (Pubitemid 35025708)
11. A. Belloni-Fortina, D. Faggion, B. Pigozzi, A. Peserico, M. Bordignon, and V. Baldo Detection of autoantibodies against recombinant desmoglein 1 and 3 molecules in patients with pemphigus vulgaris: correlation with disease extent at the time of diagnosis and during follow-up Clin Dev Immunol 2009 2009 187864
12. T. Tha-In, J. Bayry, H.J. Metselaar, S.V. Kaveri, and J. Kwekkeboom Modulation of the cellular immune system by intravenous immunoglobulin Trends Immunol 29 2008 608 615
13. R. Clynes Protective mechanisms of IVIG Curr Opin Immunol 19 2007 646 651 (Pubitemid 350236813)